Similar Papers

Paper Title
Journal
Date
Author
Rescue from Stx2-Producing E.coli-Associated Encephalopathy by Intravenous Injection of Muse Cells in NOD-SCID Mice.
Ryo Ozuru ... Shohei Wakao
Molecular Therapy | VOL. 28
Ryo Ozuru, et. al.Ryo Ozuru ... Shohei Wakao
01 Oct 2019
Abstract A19: Immunologic dysfunctions of NSG mice confer higher engraftment levels of xenograft Ewing sarcoma metastasis in the PuMA model compared to NOD-SCID mice
Renata Scopim-Ribeiro ... Amal M El-Naggar
Cancer Research | VOL. 80
Renata Scopim-Ribeiro, et. al.Renata Scopim-Ribeiro ... Amal M El-Naggar
15 Jul 2020
Intravenous Injection of Muse Cells as a Potential Therapeutic Approach for Epidermolysis Bullosa
Yasuyuki Fujita ... Hiroshi Shimizu
Journal of Investigative Dermatology | VOL. 141
Yasuyuki Fujita, et. al.Yasuyuki Fujita ... Hiroshi Shimizu
12 Jun 2020
Lack of tumorigenesis and protumorigenic activity of human umbilical cord mesenchymal stem cells in NOD SCID mice
Jie He ... Xiang-Qing Zhu
BMC Cancer | VOL. 22
Jie He, et. al.Jie He ... Xiang-Qing Zhu
22 Mar 2022
View more papers

More From: Molecular Therapy

Paper Title
Journal
Date
Author
Targeting the TRIM21-PD-1 axis potentiates immune checkpoint blockade and CAR T cell therapy
Jie Shi ... Jinfang Zhang
Molecular Therapy | VOL. -
Jie Shi, et. al.Jie Shi ... Jinfang Zhang
01 Feb 2025
The Deubiquitinase USP28 Maintains the Expression of PPARγ and Its Inactivation Protects Mice from Diet-Induced MASH and Hepatocarcinoma
Changzhou Cai ... Chengfu Xu
Molecular Therapy | VOL. -
Changzhou Cai, et. al.Changzhou Cai ... Chengfu Xu
01 Feb 2025
Gene editing of CD3 epsilon gene to redirect regulatory T cells for adoptive T cell transfer
Weijie Du ... Dimitrios L Wagner
Molecular Therapy | VOL. -
Weijie Du, et. al.Weijie Du ... Dimitrios L Wagner
01 Feb 2025
Development of RelB-Targeting Small Molecule Inhibitors of Non-canonical NF-κB Signaling with Antitumor Efficacy
Cuifeng Li ... Xiaoren Zhang
Molecular Therapy | VOL. -
Cuifeng Li, et. al.Cuifeng Li ... Xiaoren Zhang
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.